Article Information
History
- December 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sébastien Benzekry1,*,#,
- Mathieu Grangeon2,*,
- Mélanie Karlsen1,
- Maria Alexa1,
- Isabella Bicalho-Frazeto1,
- Solène Chaleat2,
- Pascale Tomasini2,3,
- Dominique Barbolosi1,
- Fabrice Barlesi3,4 and
- Laurent Greillier1,2
- 1COMPutational pharmacology and clinical Oncology Department, Inria Sophia Antipolis – Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France
- 2Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France
- 3Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France
- 4Gustave Roussy Cancer Campus, International Center of Thoracic Cancers, Université Paris-Saclay, Villejuif, France
- ↵#Corresponding author; email: sebastien.benzekry{at}inria.fr
↵* these authors contributed equally
Posted December 02, 2021.
Machine learning for prediction of immunotherapy efficacy in non-small cell lung cancer from simple clinical and biological data
